Table of Contents Table of Contents
Previous Page  3 / 9 Next Page
Information
Show Menu
Previous Page 3 / 9 Next Page
Page Background

1324 

B

rown

et al

.

:

J

ournal of

AOAC I

nternational

V

ol

. 97, N

o

. 5, 2014

A validated method can also aid in future assessments regarding

safety, use, and application of

A.

vera

products.

Experimental

Principle

This method is used to detect and quantify aloin A and aloin B

in

A.

vera

leaf juice, dietary supplements, and finished products

by HPLC with a diode array detector (DAD). This method has

been summarized in the American Herbal Pharmacopeia (AHP)

monograph for

A.

vera

leaf, leaf juice, and inner leaf juice (17).

The focus of the validation study is the diastereomers

aloin A (barbaloin) and aloin B (isobarbaloin), although other

anthraquinone-type compounds are known to exist in

A.

vera

containing materials. These diastereomers are present in the

latex of the plant, which is removed during processing of raw

materials into juices and other finished products since recent

studies have shown adverse effects when they are consumed in

sufficient quantities.

Test Samples

The validation consisted of nine test materials.

(

a

) 

A. vera inner leaf dry juice powder A

.—Obtained from

Tampa Bay Analytical Research (Tampa Bay, FL).

(

b

) 

A. vera inner leaf dry juice powder B

.—Obtained from

Tampa Bay Analytical Research.

(

c

) 

A. vera nondecolorized leaf dry juice powder

.—Obtained

fromAloecorp (Ontario, Canada).

(

d

) 

A. vera decolorized inner leaf dry juice powder

.—

Obtained fromAloecorp.

(

e

) 

A. vera leaf juice powder capsule

.—Obtained fromTampa

Bay Analytical Research.

(

f

) 

A. vera nondecolorized leaf juice

.—Obtained from

Aloecorp.

(

g

) 

A. vera decolorized leaf juice

.—Obtained fromAloecorp.

(

h

) 

A. vera nondecolorized inner leaf juice

.—Obtained from

Aloecorp.

(

i

) 

A. vera nondecolorized inner leaf juice concentrate

.—

Obtained fromAloecorp.

All solid test samples were stored in a desiccator at room

temperature, and liquid test samples were stored at 4°C. For

capsules, to minimize variability due to nonuniformity between

dosage units, contents of 20 capsules were combined and

homogenized prior to analysis.

Reagents and Supplies

(

a

) 

Acetic acid, glacial

(C

2

H

4

O

2

).—Formula weight (FW):

60.05 g/mol; CAS No. 64.19-7, ACS reagent grade (Fisher

Scientific, Ottawa, ON, Canada) or equivalent.

(

b

) 

Methanol

(CH

4

O).—FW: 32.04 g/mol; CAS No. 67-65-1,

HPLC grade (VWR International, Mississauga, ON, Canada) or

equivalent.

(

c

) 

Acetonitrile

(C

2

H

3

N).—FW: 60.10 g/mol, CAS No. 75-

05-08, HPLC grade (VWR International) or equivalent.

(

d

) 

Water

(H

2

O).—FW: 18.01 g/mol; CAS No. 7732-18-5,

HPLC grade (Fisher Scientific) or equivalent.

Solutions

(

a

) 

Reference standard diluent

.—100% methanol.

(

b

) 

Extraction solvent for high concentration test

materials

.—0.1% (v/v) acetic acid in methanol.

(

c

) 

Extraction solvent for low concentration test

materials

.—0.1% (v/v) acetic acid in water.

(

d

) 

Mobile phase A

.—0.1% (v/v) acetic acid in water (filtered

through a 0.2 µm nylon filter).

(

e

) 

Mobile phase B

.—0.1% (v/v) acetic acid in acetonitrile.

Reference Standards

Separate stock solutions of 100 µg/mL aloin A and aloin B

are prepared by dissolving 2.83 mg aloin A in 25.0 mL reference

standard diluent and 2.74 mg aloin B in 25.0 mL reference

standard diluent. The stock solution of aloin A is then diluted to

appropriate concentrations for external calibration. The aloin B

stock solution is used as a QC sample.

(

a

) 

Aloin A

(C

21

H

22

O

9

).—FW: 418.39 g/mol; CAS No. 8015-

61-0, purity 88.4%, acquired from Chromadex (Irvine, CA), Cat.

No. 1625.

(

b

) 

Aloin B

(C

21

H

22

O

9

).—FW: 418.39 g/mol; CAS No. 8015-

61-0, purity 91.3%, acquired from Chromadex, Cat. No. 1626.

Reference standards are stored at 4°C until use.

Apparatus

(

a

) 

Analytical balance

.—Capable of reading ±0.01 mg

(Mettler Toledo, Vancouver, BC, Canada) or equivalent.

(

b

) 

HPLC vials

.—Clear, volume 300 µL (Phenomenex,

Torrance, CA).

(

c

) 

Centrifuge

.—Eppendorf 5810 table top centrifuge (VWR

International) or equivalent.

(

d

) 

Centrifuge tubes

.—15 mL polypropylene (VWR

International).

(

e

) 

Micropipets

.—Eppendorf Reference series 100, 200, and

1000 µL (Eppendorf, Mississauga, ON, Canada) or equivalent.

(

f

) 

Solvent bottles

.—100, 500, and 1000 mL.

(

g

) 

Syringe filters

.—Luer-lok

®

type, 0.2 µm PTFE (VWR

International).

(

h

) 

Disposable syringes

.—3 mL screw-type (VWR

International).

(

i

) 

Sonicating water bath

.—Bransonic 3510 (VWR

International) or equivalent.

(

j

) 

Vortex mixer

.—Thermo Scientific Maxi Mix1 (VWR

International) or equivalent.

(

k

) 

Volumetric flasks

.—Class A; 2, 5, and 10 mL.

(

l

) 

Volumetric pipets

.—Class A; 1, 2, 4, and 8 mL.

HPLC Conditions

(

a

)

 Instrument

.—The HPLC system must be equipped with

a DAD or UV detector, sample injection system, pump capable

of delivering constant flow up to 400 bar, temperature-controlled

column compartment, and computing data processor.

(

b

) 

Autosampler temperature

.—Room temperature.